Bio-Rad Laboratories acquired Stilla Technologies and received $250 million from Sartorius AG shares.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bio-Rad Laboratories acquired Stilla Technologies and received $250 million from Sartorius AG shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sartorius AG
German technology company specializing in equipment and services for the biopharmaceutical industry
-
Bio-Rad Laboratories
American life science research firm
- Strategic acquisitions and product launches are driving growth for Bio-Rad Laboratories in the life science ddPCR and clinical diagnostics markets.
- Bio-Rad Laboratories is applying digital PCR technology through current partnerships, including Biodesix, Gencove, Insight Molecular, and Stilla Technologies.
Related events
Coverage
Newest first; wire copies grouped- GuruFocus.comBio-Rad Laboratories Inc (BIO) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges Net Sales: $652 million, a 2.1% increase from $638 million in Q2 2024. Life Science Group Sales: $